Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study.
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Patients with a clinical diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP) were randomised in a double-blind, placebo-controlled multicentre trial to investigate whether high-dose intravenous immunoglobulin treatment (IVIg) for 5 consecutive days has a beneficial effect. Fifteen patients were randomised to IVIg and 13 to placebo. In the IVIg treatment group 4 patients improved and 3 patients in the placebo group. The degree of improvement of the patients in the IVIg treatment group was no different from the patients in the placebo group. Electrophysiological studies did not show significant differences between the groups. Since a previously performed cross-over trial showed that a selected group of CIDP patients responded better to IVIg than to placebo, it is concluded that we need better criteria to select CIDP patients for treatment with IVIg.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interobserver agreement for the assessment of handicap in stroke patients
van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J., & van Gijn, J. (1988) · Stroke · doi:10.1161/01.str.19.5.604 · Cited by 6,512
Kleyweg, R. P., Van Der Meché, F. G. A., & Schmitz, P. I. M. (1991) · Muscle & Nerve · doi:10.1002/mus.880141111 · Cited by 926
Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)
Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force (1991) · Neurology · doi:10.1212/wnl.41.5.617 · Cited by 856
Chronic Inflammatory Polyradiculoneuropathy
Millichap, J. G. (1997) · Pediatric Neurology Briefs · doi:10.15844/pedneurbriefs-11-12-6 · Cited by 822
Plasma Exchange in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Dyck, P. J., Daube, J., O'Brien, P., Pineda, A., Low, P. A., Windebank, A. J., & Swanson, C. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140801 · Cited by 489
Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment
Dyck, P. J., O'Brien, P. C., Oviatt, K. F., Dinapoli, R. P., Daube, J. R., Bartleson, J. D., Mokri, B., Swift, T., Low, P. A., & Windebank, A. J. (1982) · Annals of Neurology · doi:10.1002/ana.410110205 · Cited by 483
Chronic relapsing (Dysimmune) polyneuropathy: Pathogenesis and treatment
Dalakas, M. C., & Engel, W. K. (1981) · Annals of Neurology · doi:10.1002/ana.410090719 · Cited by 291
Doorn, P. A. V., Brand, A., Strengers, P. F. W., Meulstee, J., & Vermeulen, M. (1990) · Neurology · doi:10.1212/wnl.40.2.209 · Cited by 274
Self-citationPlasma and gamma-globulin infusion in chronic inflammatory polyneuropathy
Vermeulen, M., van der Meché, F. G. A., Speelman, J. D., Weber, A., & Busch, H. F. M. (1985) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(85)90173-x · Cited by 178
Self-citation
Cited by
Willison, H. J., Jacobs, B. C., & van Doorn, P. A. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00339-1 · Cited by 1,609
Self-citationHughes, R. A., Donofrio, P., Bril, V., Dalakas, M. C., Deng, C., Hanna, K., Hartung, H.-P., Latov, N., Merkies, I. S., & van Doorn, P. A. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70329-0 · Cited by 674
Self-citationHughes, R., Bensa, S., Willison, H., Van Den Bergh, P., Comi, G., Illa, I., Nobile‐Orazio, E., Van Doorn, P., Dalakas, M., Bojar, M., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1088 · Cited by 628
Self-citationJoint Task Force of the EFNS and the PNS (2010) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2010.00245.x · Cited by 539
Chronic Inflammatory Demyelinating Polyneuropathy
Köller, H., Kieseier, B. C., Jander, S., & Hartung, H.-P. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041347 · Cited by 511
Dyck, P. J., Litchy, W. J., Kratz, K. M., Suarez, G. A., Low, P. A., Pineda, A. A., Windebank, A. J., Karnes, J. L., & O'Brien, P. C. (1994) · Annals of Neurology · doi:10.1002/ana.410360607 · Cited by 471
Fazekas, F., Deisenhammer, F., Strasser-Fuchs, S., Nahler, G., & Mamoli, B. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09377-4 · Cited by 381
Intravenous immunoglobulin in neurology—mode of action and clinical efficacy
Lünemann, J. D., Nimmerjahn, F., & Dalakas, M. C. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.253 · Cited by 301
Advances in the diagnosis, pathogenesis and treatment of CIDP
Dalakas, M. C. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.121 · Cited by 296
Patwa, H. S., Chaudhry, V., Katzberg, H., Rae-Grant, A. D., & So, Y. T. (2012) · Neurology · doi:10.1212/wnl.0b013e31824de293 · Cited by 254
Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy
Eftimov, F., Winer, J. B., Vermeulen, M., de Haan, R., & van Schaik, I. N. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001797.pub3 · Cited by 165
Self-citationvan der Mech�, F. G. A., & van Doorn, P. A. (1995) · Annals of Neurology · doi:10.1002/ana.410370704 · Cited by 131
Metadata
- Authors
- Vermeulen, M., van Doorn, P. A., Brand, A., Strengers, P. F., Jennekens, F. G., & Busch, H. F.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 1993-01-01
- Volume
- 56
- Issue
- 1
- Pages
- 36-39
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2119762128
- Cited by
- 223
- References
- 15
- FWCI
- 7.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.